Cited by 81Sleep and related disordersTryptophan and brain disordersSleep and Wakefulness Research

Protein source tryptophan versus pharmaceutical grade tryptophan as an efficacious treatment for chronic insomnia

Hudson, Craig, Hudson, Susan Patricia, Hecht, Tracy, MacKenzie, Joan·2005·Nutritional Neuroscience

Abstract

BACKGROUND: Intact protein rich in tryptophan was not seen as an alternative to pharmaceutical grade tryptophan since protein also contains large neutral amino acids (LNAAs) that compete for transport sites across the blood-brain barrier (BBB). Deoiled gourd seed (an extremely rich source of tryptophan-22 mg tryptophan/1 g protein) was combined with glucose, a carbohydrate that reduces serum levels of competing LNAAs which was then compared to pharmaceutical grade tryptophan with carbohydrate as well as carbohydrate alone. METHOD: Objective and subjective measures of sleep were employed to measure changes in sleep as part of a double blind placebo controlled study where subjects were randomly assigned to one of three conditions: (1) Protein source tryptophan (deoiled gourd seed) in combination with carbohydrate; (2) pharmaceutical grade tryptophan in combination with carbohydrate; (3) carbohydrate alone. SUBJECTS: Out of 57 subjects 49 of those who began the study completed the three week protocol. RESULTS: Protein source tryptophan with carbohydrate and pharmaceutical grade tryptophan, but not carbohydrate alone, resulted in significant improvement on subjective and objective measures of insomnia. Protein source tryptophan with carbohydrate alone proved effective in significantly reducing time awake during the night. CONCLUSION: Protein source tryptophan is comparable to pharmaceutical grade tryptophan for the treatment of insomnia.

Integrity signals

Registry

Crossref · 10.1080/10284150500069561

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In a comparison of food bars, Food 1 (25 g deoiled butternut squash seed meal and 25 g dextrose) and Food 2 (250 mg pharmaceutical tryptophan) produced significant results (p ≤ 0.05) for reduction of time awake during the night (19.2% and 22.1%), increased sleep efficiency (5.19% and 7.36%) and increased subjective sleep quality (12.2% and 11.8%).

    “Food 1 and Food 2 produced significant results (p ≤ 0.05) for reduction of time awake during the night (19.2% and 22.1%), increased sleep efficiency (% of time spent in bed; asleep) (5.19% and 7.36%) and increased subjective sleep quality (12.2% and 11.8%) [53], indicating that relatively small doses (250 mg) of dietary tryptophan can positively impact sleep.”

    From Sleep and Nutrition Interactions: Implications for Athletes (2019) · cites this paper as [53]

  • Relatively small doses (250 mg) of dietary tryptophan can positively impact sleep.

    “indicating that relatively small doses (250 mg) of dietary tryptophan can positively impact sleep.”

    From Sleep and Nutrition Interactions: Implications for Athletes (2019) · cites this paper as [53]

  • Dietary tryptophan has been shown to improve sleep.

    “Dietary tryptophan has been shown to improve sleep, in a comparison of food bars (Food 1: 25 g deoiled butternut squash seed meal and 25 g dextrose, Food 2: 250 mg of pharmaceutical tryptophan and Food 3: 50 g rolled oats [control]) [53].”

    From Sleep and Nutrition Interactions: Implications for Athletes (2019) · cites this paper as [53]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Hudson, C., Hudson, S. P., Hecht, T., & MacKenzie, J.
Affiliations
Concordia University (CA)
Venue
Nutritional Neuroscience
Published
2005-04
Volume
8
Issue
2
Pages
121-127
ISSN
  • 1028-415X (ISSN-L)
  • 1476-8305
OpenAlex
W2004548153
Cited by
81
References
21
Citations by year
2026: 2 · 2025: 7 · 2024: 4 · 2023: 7 · 2022: 8 · 2021: 6 · 2020: 7 · 2019: 4 · 2018: 1 · 2017: 9 · 2016: 2 · 2015: 3 · 2014: 4 · 2013: 1 · 2012: 2
FWCI
1.72
Type
journal article
Language
en
Open access
closed
Locations
  • Nutritional Neuroscience (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Sleep and Wakefulness Research
Keywords
tryptophan, chronic insomnia, carbohydrates, large neutral amino acids, blood-brain barrier, sleep
MeSH terms
Biological Availability, Blood-Brain Barrier, Chronic Disease, Dietary Carbohydrates, Dietary Proteins, Double-Blind Method, Pharmaceutical Preparations, Female, Humans, Sleep Initiation and Maintenance Disorders, Male, Middle Aged, Placebos, Seeds, Sleep, Time Factors, Tryptophan, Wakefulness, Twin Studies as Topic, Avena, Cucurbita

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review